Literature DB >> 2566169

Virus-induced delayed-type hypersensitivity reaction is sequentially mediated by CD8+ and CD4+ T lymphocytes.

D Moskophidis1, F Lehmann-Grube.   

Abstract

After subcutaneous inoculation into the hind foot of a mouse, the lymphocytic choriomeningitis (LCM) virus multiplies locally, attaining 10(7)-10(8) mouse infectious units per g of tissue; elimination commences around day 7. About 1 day earlier, the foot begins to swell, which is regarded as a delayed-type hypersensitivity (DTH) reaction. To answer the question of whether the local inflammatory response is involved in virus clearance, we needed to known what cells mediate both these phenomena. With three different procedures--namely, depletion in vivo of defined cells by treatment of mice with monoclonal antibodies ("serologic surgery"), adoptive immunization with negatively selected cells, and adoptive immunization with cells from mice differing at the major histocompatibility gene complex--it is shown that the LCM virus-induced local DTH reaction consists of two phases that are sequentially mediated by (first) class I-restricted cytotoxic/suppressive CD8+ and (second) class II-restricted helper/inducer CD4+ T lymphocytes. In contrast, for virus elimination only the former subset of T lymphocytes was found to be needed. Thus, an association may exist between the CD8+ cell-mediated component of the local DTH response and control of the infection, but the CD4+ cell-mediated part appears to be of doubtful antiviral relevance.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2566169      PMCID: PMC287117          DOI: 10.1073/pnas.86.9.3291

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  The foot pad reaction of mice to lymphocytic choriomeningitis virus.

Authors:  J HOTCHIN
Journal:  Virology       Date:  1962-05       Impact factor: 3.616

2.  Functional analysis of T lymphocyte subsets in antiviral host defense.

Authors:  T P Leist; S P Cobbold; H Waldmann; M Aguet; R M Zinkernagel
Journal:  J Immunol       Date:  1987-04-01       Impact factor: 5.422

3.  Skin allograft rejection by L3/T4+ and Lyt-2+ T cell subsets.

Authors:  S Cobbold; H Waldmann
Journal:  Transplantation       Date:  1986-05       Impact factor: 4.939

4.  Induction of tolerance by monoclonal antibody therapy.

Authors:  R J Benjamin; H Waldmann
Journal:  Nature       Date:  1986 Apr 3-9       Impact factor: 49.962

5.  Quantitative assay of the lytic action of immune lymphoid cells on 51-Cr-labelled allogeneic target cells in vitro; inhibition by isoantibody and by drugs.

Authors:  K T Brunner; J Mauel; J C Cerottini; B Chapuis
Journal:  Immunology       Date:  1968-02       Impact factor: 7.397

6.  Immunopathologic alterations of lymphatic tissues of mice infected with lymphocytic choriomeningitis virus. II. Pathogenetic mechanism.

Authors:  F Lehmann-Grube; J Löhler
Journal:  Lab Invest       Date:  1981-03       Impact factor: 5.662

7.  H-2 compatibility requirement for virus-specific T cell-mediated effector functions in vivo. I. Specificity of T cells conferring antiviral protection against lymphocytic choriomeningitis virus is associated with H-2K and H-2D.

Authors:  R M Zinkernagel; R M Welsh
Journal:  J Immunol       Date:  1976-11       Impact factor: 5.422

8.  Two T-cell populations mediate delayed-type hypersensitivity to murine influenza virus infection.

Authors:  K N Leung; G L Ada
Journal:  Scand J Immunol       Date:  1980       Impact factor: 3.487

9.  Mechanism of recovery from acute virus infection. I. Role of T lymphocytes in the clearance of lymphocytic choriomeningitis virus from spleens of mice.

Authors:  F Lehmann-Grube; U Assmann; C Löliger; D Moskophidis; J Löhler
Journal:  J Immunol       Date:  1985-01       Impact factor: 5.422

10.  Properties and applications of monoclonal antibodies directed against determinants of the Thy-1 locus.

Authors:  A Marshak-Rothstein; P Fink; T Gridley; D H Raulet; M J Bevan; M L Gefter
Journal:  J Immunol       Date:  1979-06       Impact factor: 5.422

View more
  19 in total

1.  Innate signals compensate for the absence of PKC-{theta} during in vivo CD8(+) T cell effector and memory responses.

Authors:  Benjamin J Marsland; Chiara Nembrini; Nicole Schmitz; Brian Abel; Stefan Krautwald; Martin F Bachmann; Manfred Kopf
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-26       Impact factor: 11.205

2.  Antiviral immune responses in Itk-deficient mice.

Authors:  M F Bachmann; D R Littman; X C Liao
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

3.  Genomic and biological characterization of aggressive and docile strains of lymphocytic choriomeningitis virus rescued from a plasmid-based reverse-genetics system.

Authors:  Minjie Chen; Shuiyun Lan; Rong Ou; Graeme E Price; Hong Jiang; Juan Carlos de la Torre; Demetrius Moskophidis
Journal:  J Gen Virol       Date:  2008-06       Impact factor: 3.891

4.  Antiviral immune responses in CTLA4 transgenic mice.

Authors:  C Zimmermann; P Seiler; P Lane; R M Zinkernagel
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

5.  Effects of promyelocytic leukemia protein on virus-host balance.

Authors:  Weldy V Bonilla; Daniel D Pinschewer; Paul Klenerman; Valentin Rousson; Mirella Gaboli; Pier P Pandolfi; Rolf M Zinkernagel; Maria S Salvato; Hans Hengartner
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

6.  In situ suppression of delayed-type hypersensitivity: another mechanism for sustaining the immune privilege of the anterior chamber.

Authors:  J L Benson; J Y Niederkorn
Journal:  Immunology       Date:  1991-09       Impact factor: 7.397

7.  Regulation of immune response and inflammatory reactions against viral infection by VCAM-1.

Authors:  Rong Ou; Menghua Zhang; Lei Huang; Richard A Flavell; Pandelakis A Koni; Demetrius Moskophidis
Journal:  J Virol       Date:  2008-01-23       Impact factor: 5.103

8.  Lentiviral transduction of dendritic cells confers protective antiviral immunity in vivo.

Authors:  Shohreh Zarei; Shahnaz Abraham; Jean-Francois Arrighi; Olivier Haller; Thomas Calzascia; Paul R Walker; Thomas M Kündig; Conrad Hauser; Vincent Piguet
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

9.  Antiviral defense in mice lacking both alpha/beta and gamma interferon receptors.

Authors:  M F van den Broek; U Müller; S Huang; M Aguet; R M Zinkernagel
Journal:  J Virol       Date:  1995-08       Impact factor: 5.103

10.  Antiviral immune responses in mice deficient for both interleukin-2 and interleukin-4.

Authors:  M F Bachmann; H Schorle; R Kühn; W Müller; H Hengartner; R M Zinkernagel; I Horak
Journal:  J Virol       Date:  1995-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.